Enzolytics Inc
OTC Pink - Limited Information:ENZC

  • LAST PRICE
    0.0043
  • TODAY'S CHANGE (%)
    0.0001 (2.8708%)
  • Bid / Lots
    0.0042/ 239
  • Ask / Lots
    0.0044/ 2,000
  • Open / Previous Close
    0.0042 / 0.0042
  • Day Range
    0.0036
    0.0055
  • 52 Week Range
    0.0016
    0.1320
  • Volume
    37,297,480

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Biotechnology Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
ENZC
Enzolytics Inc
12.4M
0.0x
---
IMNN
Imunon Inc
12.5M
-0.6x
---
MBOT
Microbot Medical Inc
12.7M
-0.8x
---
MIRA
Mira Pharmaceuticals Inc
13.0M
-1.0x
---
ATHE
Alterity Therapeutics Ltd
20.3M
-1.2x
---
PPBT
Purple Biotech Ltd
13.4M
-0.6x
---
As of 2024-04-24

Company Information

Enzolytics, Inc. is a drug development company. The Company is engaged in the commercialization of its proteins and monoclonal antibodies for the treatment of debilitating infectious diseases. Its patented and clinically tested compound, ITV-1 (Immune Therapeutic Vaccine-1), is a suspension of Inactivated Pepsin Fraction (IPF) for the treatment of human immunodeficiency virus/ acquired immunodeficiency syndrome (HIV/AIDS). It has a technology for producing fully human monoclonal antibodies (mAbs) against infectious diseases which is being employed to produce monoclonal antibody therapeutics for treating the Coronavirus (SARS-CoV-2), HIV-1 and the Feline Leukemia virus. The Company also plans to produce mAbs targeting many other viruses, including HIV-2, Influenza A and B, H1N1 influenza, Respiratory syncytial virus (RSV), Small-Pox, Ebola Virus, Tetanus, Diphtheria, HTLV-1/2, Rabies, Herpes zoster, Varicella zoster, Anthrax, Mason-Pfizer monkey virus (MPMV) and Visna virus (VISNA).

Contact Information

Headquarters
120 W Pomona AveMONROVIA, CA, United States 91016
Phone
626-538-4779
Fax
845-818-3588

Executives

No data available

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$12.4M
Revenue (TTM)
$0.00
Shares Outstanding
3.0B
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.82
EPS
$-0.11
Book Value
$-0.96
P/E Ratio
0.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.